stock
TVTX · Travere Therapeutics, Inc.
What Travere Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live TVTX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on TVTX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 94,261,082 as of 2026-07-30 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -6.8%
- Net
- -7.4%
Returns
- ROE
- -177.2%
- ROA
- -5.4%
Health
- Current ratio
- 4.0x
- Debt/equity
- —
Deep value
- NCAV
- -$159.70M
- NCAV per share
- -$1.69
- Price/NCAV
- Locked
- NNWC
- -$576.60M
- NNWC per share
- -$6.12
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $169.58M | —Gross profit: unreported by this company. | $3.95M | -$34.80M | 10-Q filed 2026-08-04 |
| 2026-03-31 | $127.20M | —Gross profit: unreported by this company. | -$36.91M | -$37.10M | 10-Q filed 2026-05-04 |
| 2025-12-31 | $129.69M | —Gross profit: unreported by this company. | -$32.43M | $2.73M | DEF 14A filed 2026-04-06 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $164.86M | —Gross profit: unreported by this company. | $24.93M | $25.71M | 10-Q filed 2025-10-30 |
| 2025-06-30 | $114.45M | —Gross profit: unreported by this company. | -$12.65M | -$12.76M | 10-Q filed 2026-08-04 |
| 2025-03-31 | $81.73M | —Gross profit: unreported by this company. | -$42.67M | -$41.23M | 10-Q filed 2026-05-04 |
| 2024-12-31 | $74.79M | —Gross profit: unreported by this company. | -$60.74M | -$60.26M | DEF 14A filed 2026-04-06 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $62.90M | —Gross profit: unreported by this company. | -$56.15M | -$54.81M | 10-Q filed 2025-10-30 |
- Assets
- $799.36M
- Equity
- $24.52M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $490.73M | -$62.82M | -$25.55M | — |
| 2024-12-31 | $233.18M | -$323.83M | -$321.55M | — |
| 2023-12-31 | $145.24M | -$388.14M | -$111.40M | -$280.69M |
| 2022-12-31 | $109.46M | -$319.81M | -$278.48M | -$186.48M |
| 2021-12-31 | $131.84M | -$199.43M | -$180.09M | -$19.89M |
| 2020-12-31 | $198.32M | -$176.16M | -$169.43M | -$49.51M |
| 2019-12-31 | $175.34M | -$137.36M | -$146.43M | -$58.41M |
| 2018-12-31 | $164.25M | -$80.04M | -$102.68M | -$25.68M |
| 2017-12-31 | $154.94M | -$53.79M | -$59.73M | $6.52M |
| 2016-12-31 | $133.59M | -$58.21M | -$47.90M | -$4.87M |
Company filings
2 offering filings in 12 months
events
Executive or director change
Executive or director changeSep 218-KResults
ResultsAug 48-KExecutive or director change
Executive or director changeJul 98-KExecutive or director change
Executive or director changeJun 168-KMaterial agreement
Material agreementJun 28-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsMay 218-K
5% owners ()
Armistice Capital, LLC
Stake update
BANK OF AMERICA CORP /DE/
Passive stake
STATE STREET CORPORATION
Passive stake
FMR LLC
Stake update
Armistice Capital, LLC
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
ROTE WILLIAM E.
Chief Research Officer
Sale$13,135,397Sep 17, 9:35 PM ET
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
Sale$17,857,830Sep 17, 9:35 PM ET
Inrig Jula
EVP, Head of R&D & CMO
Sale$2,785,021Sep 17, 9:33 PM ET
REED ELIZABETH E
Chief Legal Officer and GC
Sale$2,337,695Sep 17, 9:32 PM ET
Dube Eric M
CHIEF EXECUTIVE OFFICER, Director
Sale$25,390,729Sep 17, 9:31 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Point72
Period Tue 30 Jun 2026
0.0%New - Polen Capital
Period Tue 30 Jun 2026
0.0%New
News
Stories that named TVTX, and the market events around them.
Sign in to see thisBoard
The TVTX board could not be loaded.
Retry the TVTX boardnakagai
Signals on TVTX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the TVTX board